<DOC>
	<DOCNO>NCT00001605</DOCNO>
	<brief_summary>Acute otitis medium ( OM ) OM effusion common childhood disease . Otitis medium condition mark inflammation middle ear . Otitis medium effusion typically mean long-term ( chronic ) middle ear inflammation secretion fluid middle ear due blockage canal lead middle ear mouth ( eustachian tube ) . The fluid involve sterile ( organism ) infect disease cause organism , bacteria virus . Nontypeable Haemophilus influenzae ( NTHi ) bacteria one leading cause OM respiratory infection old people . NTHi carry substance surface call antigen . When antigens come contact right kind cell body , immune reaction cause . This reaction often symptoms sickness patient feel . One major antigen surface NTHi call lipooligosaccharide ( LOS ) . In order body fight attack antigen , creates substance call antibody . Antibodies counter action antigen make bacteria harmless . However , immune system must learn make right antibody right antigens . This do give vaccine . Vaccines contain small amount inactive form antigen . Once immune system recognize antigen start make antibody prevent sickness ever expose antigen . Presently vaccines NTHi . One reason vaccine NTHi antigen , LOS , toxic give human . Researchers try make antigen less dangerous remove toxic effect . It refer dLOS . Unfortunately , dLOS unable start antibody production . However , researcher find combine dLOS another vaccine tetanus ( tetanous toxoid ) , able stimulate immune system create antibody laboratory animal . These laboratory animal protect NTHi infection otitis medium ( OM ) . Researchers would like test effectiveness safety dLOS-TT vaccine adult human . Their ultimate goal develop vaccine OM respiratory infection cause NTHi .</brief_summary>
	<brief_title>Vaccination Middle Ear Infection</brief_title>
	<detailed_description>Acute otitis medium ( OM ) OM effusion common childhood disease . Nontypeable Haemophilus influenzae ( NTHi ) lead cause OM respiratory infection older individual . Currently , vaccine NTHi infection . Studies indicate serum bactericidal antibody associate protection NTHi infection . We predict serum antibody bactericidal activity lipooligosaccharide ( LOS ) , major surface antigen virulence factor NTHi , confer immunity pathogen . LOS NTHi toxic administer human detoxify LOS ( dLOS ) immunogenic , probably due low molecular weight . In order improve immunogenicity , dLOS convalently bind tetanus toxoid ( TT ) use clinically relevant scheme vaccination , elicit bactericidal antibody LOS vivo model . This investigational vaccine also show protection infection chinchilla otitis medium model . We propose evaluate safety immunogenicity dLOS-TT vaccine adult ( Phase I ) . Our goal develop vaccine OM respiratory infection cause NTHi .</detailed_description>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<criteria>Healthy volunteer age 18 35 year . Not pregnant plan become pregnant next six month . HIV negative . Hepatitis B Negative . No chronic Respiratory Tract Infections . No history abnormal immune system . No severe multiple allergy .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2000</verification_date>
	<keyword>Conjugate Vaccine</keyword>
	<keyword>Detoxified Lipooligosaccharide</keyword>
	<keyword>Tetanus Toxoid</keyword>
	<keyword>Normal Volunteers</keyword>
</DOC>